Inmune Bio (INMB) Shares Outstanding (2017 - 2025)
Historic Shares Outstanding for Inmune Bio (INMB) over the last 9 years, with Q3 2025 value amounting to $26.6 million.
- Inmune Bio's Shares Outstanding rose 1990.22% to $26.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.6 million, marking a year-over-year increase of 1990.22%. This contributed to the annual value of $22.3 million for FY2024, which is 2411.97% up from last year.
- As of Q3 2025, Inmune Bio's Shares Outstanding stood at $26.6 million, which was up 1990.22% from $26.6 million recorded in Q2 2025.
- Inmune Bio's Shares Outstanding's 5-year high stood at $26.6 million during Q2 2025, with a 5-year trough of $14.9 million in Q1 2021.
- Moreover, its 5-year median value for Shares Outstanding was $17.9 million (2022), whereas its average is $19.3 million.
- As far as peak fluctuations go, Inmune Bio's Shares Outstanding surged by 3894.77% in 2021, and later changed by 0.0% in 2023.
- Quarter analysis of 5 years shows Inmune Bio's Shares Outstanding stood at $17.8 million in 2021, then rose by 0.58% to $17.9 million in 2022, then increased by 0.03% to $18.0 million in 2023, then rose by 24.12% to $22.3 million in 2024, then increased by 19.32% to $26.6 million in 2025.
- Its Shares Outstanding was $26.6 million in Q3 2025, compared to $26.6 million in Q2 2025 and $22.9 million in Q1 2025.